GKWIM
DNA icon

Gerber Kawasaki Wealth & Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250
Closed -$3.34K – 291
2024
Q2 		$3.34K Hold
250
– – ﹤0.01% 282
2024
Q1 		$11.6K Hold
250
– – ﹤0.01% 283
2023
Q4 		$16.9K Hold
250
– – ﹤0.01% 262
2023
Q3 		$18.1K Buy
+250
New +$20K ﹤0.01% 250

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's DNA Position: Q3 2024 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 250 shares — an estimated $3.34K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in DNA in Q3 2023 and held it in 4 quarters. The position peaked at $18.1K in Q3 2023. 158 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 250 Ginkgo Bioworks shares in Q3 2024, an estimated $3.34K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 4 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Ginkgo Bioworks position peaked at $18.1K in Q3 2023.
  • 158 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.